Amid ongoing controversy over pharmaceutical promoting, one lawmaker needs to know the way the U.S. authorities will implement laws after the Meals and Drug Administration let go of quite a few staff from the workplace that oversees prescription drug promotions.
In a letter to the FDA Commissioner Marty Makary, Sen. Dick Durbin (D-Unwell.) famous that 4 key leaders of the Workplace of Prescription Drug Promotion just lately departed the company, and your entire Division of Promotion Coverage, Analysis, and Operations — a unit inside the workplace that developed steering on pharmaceutical promoting — additionally was reportedly laid off.
“These departures increase main questions on whether or not FDA has the personnel, experience, and capability to satisfy its mission to manage prescription drug commercials,” Durbin wrote, including that the problem arises at the same time as each Makary and Well being and Human Providers Secretary Robert F. Kennedy Jr. have expressed curiosity in scrutinizing pharmaceutical promoting.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
